Company Information
HKD
0.54
- (5.9%)
SEHK:02216, BRONCUS HOLDING CORPORATION
Industry: Medical Devices
End of Day: 18 April 2024 GMT+8
Broncus Holding Corp is a medical device company focused on the development of interventional pulmonology products. It is engaged in the field of interventional pulmonology, providing innovative lung solutions in China and globally. The integrated interventional pulmonology platform addresses the pain points of the existing diagnosis and treatment paradigms and significant unmet medical needs for lung diseases by improving the diagnosis and treatment effects of lung cancer and COPD.
Address
No. 88 Jiangling Road, Xixing Street
Room 801, 8th Floor, Building 8
Binjiang District
Website
Classification
Sector
Healthcare
Industry Group
Medical Devices & Instruments
Industry
Medical Devices
Key Executives
Guowei Zhan
Executive Director and Chief Executive Officer
Hong Xu
Executive Director and Chief Technology Officer
Yi Wei Michael Zhao
Non-Executive Chairman of the Board
Zhenjun Zi
Non-Executive Director
Zhang Ao
Non-Executive Director
Dr. Man Kam Pok
Non-Executive Independent Director
Professor Yee Lau Joseph Wan
Non-Executive Independent Director
Sin Wong Yee
Non-Executive Independent Director
Kwan Ho Yin
Company Secretary
Todd A. Cornell
President of Broncus Medical and Uptake Medical
Ownership
Institution Holdings
UBS Asset Management (HK) Ltd.
5,312,000 (1.088%)
UBS Asset Management
5,179,500 (1.061%)
UBS Asset Management (Singapore) Ltd
2,136,000 (0.437%)
UBS Asset Management (Hong Kong) Limited
1,762,500 (0.361%)
China Universal Asset Mgmt Co.Ltd
1,264,500 (0.259%)
Value Partners Hong Kong Limited
884,000 (0.181%)
Azimut Capital Management SGR S.p.A.
12,245 (0.003%)
Azimut Investments S.A.
2,237 (0.000%)
JPMorgan Asset Management (UK) limited
72 (0.000%)
Funds Holdings
UBS (Lux) EF Greater China (USD)
784,000 (0.161%)
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
